Stock Research for ACST

ACST
Current Price

$0.9250


Latest Update: 2018-01-16 16:00:00

High
$ 0.9287
Low
$ 0.9250
Close
$ 0.9287
Volume
2967
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ACST Stock Chart & Research Data

The ACST chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACST chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ACST Due diligence Resources & Stock Charts

The ACST stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACST Detailed Price Forecast - CNN Money CNN View ACST Detailed Summary - Google Finance
Yahoo View ACST Detailed Summary - Yahoo! Finance Zacks View ACST Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ACST Trends & Analysis - Trade-Ideas Barrons View ACST Major Holders - Barrons
NASDAQ View ACST Call Transcripts - NASDAQ Seeking View ACST Breaking News & Analysis - Seeking Alpha
Spotlight View ACST Annual Report - CompanySpotlight.com OTC Report View ACST OTC Short Report - OTCShortReport.com
TradeKing View ACST Fundamentals - TradeKing Charts View ACST SEC Filings - Bar Chart
WSJ View Historical Prices for ACST - The WSJ Morningstar View Performance/Total Return for ACST - Morningstar
MarketWatch View the Analyst Estimates for ACST - MarketWatch CNBC View the Earnings History for ACST - CNBC
StockMarketWatch View the ACST Earnings - StockMarketWatch MacroAxis View ACST Buy or Sell Recommendations - MacroAxis
Bullish View the ACST Bullish Patterns - American Bulls Short Pains View ACST Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ACST Stock Mentions - StockTwits PennyStocks View ACST Stock Mentions - PennyStockTweets
Twitter View ACST Stock Mentions - Twitter Invest Hub View ACST Investment Forum News - Investor Hub
Yahoo View ACST Stock Mentions - Yahoo! Message Board Seeking Alpha View ACST Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ACST - SECform4.com Insider Cow View Insider Transactions for ACST - Insider Cow
CNBC View ACST Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACST - OTC Markets
Yahoo View Insider Transactions for ACST - Yahoo! Finance NASDAQ View Institutional Holdings for ACST - NASDAQ


Stock Charts

FinViz View ACST Stock Insight & Charts - FinViz.com StockCharts View ACST Investment Charts - StockCharts.com
BarChart View ACST Stock Overview & Charts - BarChart Trading View View ACST User Generated Charts - Trading View


Latest Financial News for ACST

Acasti Pharma Announces Change to Board of Directors
Posted on Tuesday January 16, 2018

Acasti Pharma Inc. , a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre for the treatment of severe hypertriglyceridemia, ...


Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures
Posted on Monday January 08, 2018

Acasti Pharma Inc. announces that in accordance with the terms of its outstanding convertible debentures in the total aggregate principal amount of $2,000,000 issued on February 21, 2017 , the Corporation ...


Acasti Expands Global Patent Portfolio with Newly Granted Patents in South Korea and Canada
Posted on Thursday January 04, 2018

Acasti Pharma Inc. , an emerging biopharmaceutical company focused on the research, development and commercialization of its prescription drug candidate CaPre for the treatment of severe hypertriglyceridemia, ...


Dawson James Securities Announces Closing of US $10 Million Firm Commitment Offering of Common Shares and Warrants for Acasti Pharma Inc.
Posted on Tuesday January 02, 2018

BOCA RATON, FL / ACCESSWIRE / January 2, 2018 / Dawson James Securities, Inc., in conjunction with Acasti Pharma Inc. (NASDAQ: ACST; TSX-V: ACST), completed an underwritten offering of 9,900,990 common ...


Acasti Pharma Announces Change to Board of Directors
Marketwired (press release) - 8 hours ago
LAVAL, QUÉBEC--(Marketwired - Jan. 16, 2018) - Acasti Pharma Inc. (NASDAQ:ACST)(TSX VENTURE:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid ...
Acasti Pharma Inc (ACST.V) Limping -2.42% For the Week - Luxora Leader
Cloud Peak Energy Inc (CLD) Shares Needle Moving -0.72% - Stock Press Daily

Acasti Pharma Inc.
MarketWatch - Nov 28, 2016
Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.

Acasti Pharma advancing potential deal to commercialize CaPre in Asia; shares ...
Seeking Alpha - Nov 20, 2017
Thinly traded nano cap Acasti Pharma (ACST +74.8%) is up on a whopping 317x surge in volume in response to its announcement that it has entered into a non-binding term sheet with a leading Chinese pharmaceutical company that it expects to lead to a ...

Acasti Pharma and CordenPharma Announce Large Scale Production of CaPre® with ...
Marketwired (press release) - May 31, 2017
LAVAL, QUEBEC--(Marketwired - May 31, 2017) - Acasti Pharma Inc. (NASDAQ:ACST)(TSX VENTURE:ACST) today announced the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPre®, Acasti's omega-3 pharmaceutical product ...

Enter a stock symbol to view the stock details.